Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (111-120 of 894) with videos related to

Pageof 90
Sort By:
Human Immunology|December 31, 2017
Mesenchymal stromal cells for tolerance induction in organ transplantationFederica Casiraghi, Norberto Perico, Giuseppe Remuzzi
Science and Engineering Ethics|October 2, 2002
Conflict of interest as seen from a researcher's perspectiveArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2003
Preventing end-stage renal disease: the potential impact of screening and intervention in developing countriesArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Nephron|July 22, 2021
Redefining the Role of Donor Biopsies in the Process of Kidney Graft AssessmentCamillo Carrara, Piero Ruggenenti, Giuseppe Remuzzi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 1, 2016
[Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Somatostatin analogues and mTOR inhibitors]Norberto Perico, Monica Cortinovis, Giuseppe Remuzzi
Kidney International|May 20, 2003
Retarding progression of chronic renal disease: the neglected issue of residual proteinuriaPiero Ruggenenti, Annalisa Perna, Giuseppe Remuzzi, et al.
Lancet (London, England)|March 18, 2008
Decision time for pancreatic islet-cell transplantationPiero Ruggenenti, Andrea Remuzzi, Giuseppe Remuzzi
Journal of Renal Care|January 24, 2009
Kidney failure stabilizes after an increase over 2 decadesPaolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi
Current Opinion in Critical Care|September 22, 2005
The hemolytic uremic syndromesJessica Caprioli, Li Peng, Giuseppe Remuzzi
Nature Clinical Practice. Nephrology|December 3, 2008
Rituximab for membranous nephropathy and immune disease: less might be enoughPiero Ruggenenti, Paolo Cravedi, Giuseppe Remuzzi
Pageof 90

Showing results (111-120 of 894) with videos related to

Sort By:
Pageof 90
Human Immunology|December 31, 2017
Mesenchymal stromal cells for tolerance induction in organ transplantationFederica Casiraghi, Norberto Perico, Giuseppe Remuzzi
Science and Engineering Ethics|October 2, 2002
Conflict of interest as seen from a researcher's perspectiveArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2003
Preventing end-stage renal disease: the potential impact of screening and intervention in developing countriesArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Nephron|July 22, 2021
Redefining the Role of Donor Biopsies in the Process of Kidney Graft AssessmentCamillo Carrara, Piero Ruggenenti, Giuseppe Remuzzi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 1, 2016
[Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Somatostatin analogues and mTOR inhibitors]Norberto Perico, Monica Cortinovis, Giuseppe Remuzzi
Kidney International|May 20, 2003
Retarding progression of chronic renal disease: the neglected issue of residual proteinuriaPiero Ruggenenti, Annalisa Perna, Giuseppe Remuzzi, et al.
Lancet (London, England)|March 18, 2008
Decision time for pancreatic islet-cell transplantationPiero Ruggenenti, Andrea Remuzzi, Giuseppe Remuzzi
Journal of Renal Care|January 24, 2009
Kidney failure stabilizes after an increase over 2 decadesPaolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi
Current Opinion in Critical Care|September 22, 2005
The hemolytic uremic syndromesJessica Caprioli, Li Peng, Giuseppe Remuzzi
Nature Clinical Practice. Nephrology|December 3, 2008
Rituximab for membranous nephropathy and immune disease: less might be enoughPiero Ruggenenti, Paolo Cravedi, Giuseppe Remuzzi
Pageof 90